SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Celsius Holdings, Inc. (OTCMKTS:CELH) 1Q2015 revenue came at $4.65 million compared to $3.87 million in 1Q2014. The international revenue stood at $3.16 million compared to $2.28 million in the same quarter last year. The domestic revenue declined to $1.49 million from $1.59 million recorded in the same period last year.

The gross profit margins jumped to 39.5% from 35.8% in 1Q2014.Net Profit surged to $213,000 versus a net loss of ($703,000) in 1Q2014. The non-GAAP adjusted EBITDA, excluding depreciation expenses, interest and stock based compensation jumped to $559,000 in 1Q2015 from ($271,000) in 1Q2014.

The highlights

Celsius management reported that they accomplished significant milestones in the first quarter of year. The improvement in prevailing international accounts validates the success of company’s second consecutive profitable quarter. The company recorded strong sales at cash registers although domestic revenues were slightly affected by the surge in promotional allowances and the timing of clients’ replenishment systems.

Domestically, Amazon.com sale was impressive with monthly sales records made in February, which were followed by a new record in sales in March. The recent expansion of company’s services into Gold’s Gym locations and product growth in The Vitamin Shoppe mirrors continued growth in the industry of health and fitness.

The management comments

Gerry David, the CEO of Celsius said that distribution across the U.S., into national as well as regional grocery chains continues to expand. As company leverages it reported association and equity investments directed by Horizons Ventures, Ms. Kimora Lee Simmons and Mr. Russell Simmons, the management is of view that that it will extend company’s reach across new consumer channels and will strengthen position in both global as well as domestic markets.

In last trading session, the stock price of Celsius Holdings, Inc. (OTCMKTS:CELH) jumped more than 7% to close the trading session at $2.83. The gains came at a share volume of 60,481 compared to average share volume of 105,566.